Obesity White Papers & Case Studies

  1. Managing Placebo Response To Improve Clinical Trial Success Rates 2/20/2026

    Many effective therapies fail in Phase 3 trials because high placebo response rates mask their true benefits. Successfully navigating this challenge requires a proactive, multi-pronged approach.

  2. Comprehensive Multi-Omics Approach To Support Biomarker Programs 2/19/2026

    Explore how a multi-omics strategy integrates genomics, transcriptomics, proteomics, spatialomics & pathomics to provide the deep biological insights needed to accelerate precision medicine and clinical development.

  3. Scaling Success: A Blueprint For Flexible Biometrics Partnerships 2/19/2026

    Learn how a micro-FSP model and integrated biometrics team can scale from specialized support to a full-service solution, ensuring agility and consistency as clinical trial needs evolve.

  4. End-To-End Inventory Control Supports Biotech's Expanding Portfolio 2/19/2026

    Many organizations struggle with siloed operations, but this modern GxP inventory solution solves these challenges by providing a centralized, cloud-based platform for end-to-end visibility.

  5. Reduce Rater Variability With Independent Expert Assessments 2/19/2026

    Optimize signal detection in CNS trials by reducing rater variability. Use expert eligibility reviews and AI-augmented monitoring to ensure reliable endpoints and protocol compliance.

  6. Biopharma Reaping Numerous Benefits From AI 2/18/2026

    Multiple AI use cases with significant impact have been identified, and they are expected to drive innovations in clinical trials, precision medicine, and commercial operations.

  7. Accelerate Enrollment And Reduce Site Burden 2/18/2026

    Driven by AI and real-world data, Citeline PatientMatch helps sponsors identify highly qualified, protocol-matched patients earlier in their care journey — when enrollment decisions matter most.

  8. The Hardest Trials Deserve The Easiest Solutions 2/13/2026

    Explore practical ways to simplify complex oncology studies with unified data, streamlined workflows, and more supportive patient and site experiences.

  9. Overcoming Challenges In Obesity Trials 2/12/2026

    Obesity trials face high dropout rates due to long durations and complex requirements. Overcome these hurdles with personalized engagement, expert lifestyle support, and proactive patient care.

  10. Precision Partnership For Obesity Clinical Trials 2/12/2026

    Accelerate obesity research with specialized expertise in GLP-1 trials. Our approach ensures rapid enrollment, high participant retention, and clean data through a patient-centered model.